BSE filing, NSE: CAMLINFINE. Summary written from the filing by ALFA Finder's alert engine.
Camlin Fine Sciences Ltd: key numbers
- Share price
- ₹74.15
- Market cap
- ₹1,424 Cr
- Revenue (annual)
- ₹1,723 Cr
- Net profit (annual)
- ₹27.63 Cr
- P/E (TTM)
- -187.7×Sector 34.1×
- Promoter holding
- 48.03%+0.00% QoQ
- FII holding
- 0.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Camlin Fine Sciences Ltd
All →Camlin Fine Sciences Earnings Call Transcript: Key Takeaways
EBITDA margin collapsed to about 0.5% from 3.4% as liquidity stress hit gross margin. A ₹250 Cr rights issue is pitched as the fix, and Q3 is described as a fight to stay afloat.
Camlin Fine Sciences Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs4,915mn (+9.2% YoY), but EBITDA margin fell to 0.45% and PAT loss was Rs281mn. Rights issue up to Rs2,500mn approved.
Camlin Fine Sciences Q2 FY27 Results: Net Loss of ₹29.7 Cr, Loss Widens
Camlin Fine Sciences Ltd reported revenue from operations of ₹491.5 Cr (+9.1% YoY) and a net loss of ₹29.7 Cr for Q2 FY27.
- Key figure
- Net loss ₹29.7 Cr
Camlin Fine Sciences Legal & Regulatory
SEBI issued an administrative warning to Camlin Fine Sciences over misclassified promoter-group shareholders in filings. No monetary penalty; compliance must improve to avoid enforcement.
Camlin Fine Sciences Board Meeting Date
Camlin Fine Sciences' board meets on 03 Nov 2026 to consider results and a proposed rights issue. Trading window closes until 05 Nov 2026.
Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr
Other business update announcements
All →ABH Healthcare Business Update
ABH Healthcare Limited has deferred the execution of its lease-and-management agreement with Sri Kailash Multispeciality Hospital. Discussions regarding final terms and conditions remain ongoing between the parties.
Ravindra Energy Business Update
Ravindra Energy reported its Q2 FY2026-27 business update, covering a 522.8 MWp renewable portfolio and 254 million kWh generation. The EIM merger scheme remains under exchange review.
- total renewable portfolio capacity (operating plus under construction)
- 522.8 MWp
Laxmi Dental Business Update
Laxmi Dental's 60%-owned Kids-e-Dental received EU MDR and ISO 13485 certificates from TÜV SÜD. The certificates allow EU marketing of its dental products after regulatory formalities.
Northern Arc Capital Business Update
Northern Arc's subsidiary reached a first close of over ₹400 Crore for its Diversified Debt Fund. The India Impact Fund matured with a 14.59% gross XIRR.
- Value
- ₹400.0 Cr
Cupid Business Update
Cupid Limited entered an exclusive long-term retail arrangement with V2 Retail, securing dedicated space across 425+ stores. Management targets about ₹400 crore incremental revenue within a year.
- Execution
- Long-term arrangement; nationwide product availability targeted by mid-December 2026; revenue expectation within 12 months
Ugro Capital Business Update
UGRO Capital released a social impact study showing 58% of borrowers saw revenue growth after loans. The study was independently conducted with Impactree.